Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.421 | -40.0952380952 | 1.05 | 1.1099 | 0.6259 | 2615234 | 0.87882055 | CS |
4 | -0.0533 | -7.81181298549 | 0.6823 | 1.1099 | 0.54 | 729607 | 0.88292398 | CS |
12 | -0.351 | -35.8163265306 | 0.98 | 1.1099 | 0.5 | 247917 | 0.87997357 | CS |
26 | -0.521 | -45.3043478261 | 1.15 | 1.87 | 0.5 | 120773 | 0.92337072 | CS |
52 | -1.091 | -63.4302325581 | 1.72 | 1.98 | 0.5 | 66273 | 0.93143532 | CS |
156 | -6.811 | -91.5456989247 | 7.44 | 9.4 | 0.5 | 65279 | 4.03167458 | CS |
260 | -10.371 | -94.2818181818 | 11 | 19.56 | 0.5 | 410112 | 10.8305622 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.